Company News

This press release is posted as a service by Angioplasty.Org


Medtronic Inc.
Company Press Releases

Jan 24, 2012 Medtronic Completes Enrollment of Extreme Risk Patient Group in CoreValve® U.S. Pivotal Trial
Jan 17, 2012 Medtronic Endurant® II AAA Stent Graft System Launches Internationally With CE Mark
Nov 8, 2011 Medtronic Resolute® Drug-Eluting Stent Shows Strong Results, Even in Challenging Diabetes Patients with Coronary Disease
Nov 8, 2011 Study of Medtronic Endeavor® Drug-Eluting Stent Demonstrates Long-Term Advantages Over Taxus® DES
Nov 7, 2011 Medtronic CoreValve® System Gains CE Mark for New Direct Aortic Approach to Transcatheter Aortic Valve Implantation
Nov 4, 2011 Medtronic's Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011
Aug 23, 2011 Medtronic Reports First Quarter Earnings
Jul 25, 2011 Medtronic Resolute® Drug-Eluting Stent Shows Superiority to Taxus ® DES in Study of Patients with Coronary Artery Disease
Jun 18, 2011 VALOR II Study Highlights Strengths of Valiant® Thoracic Stent Graft from Medtronic
May 18, 2011 Medtronic Resolute® Drug-Eluting Stent Offers Strong Performance in Diabetic Patients with Heart Disease
May 17, 2011 Medtronic CoreValve® Multi-Center Study Shows Rapid and Sustained Health-Related Quality-Of-Life Improvements
May 16, 2011 Medtronic Advances Research on Peripheral Devices, Highlights Upcoming Presentations
Apr 4, 2011 Medtronic Resolute® Drug-Eluting Stent Delivers Compelling Clinical Outcomes In Major Studies
Mar 28, 2011 Medtronic to Unveil Pivotal U.S. Data on Resolute® Drug-Eluting Stent at ACC.11
Mar 14, 2011 Medtronic Pledges $1 Million to Relief Efforts in Japan
Mar 3, 2011 Medtronic Seeking Long-Distance Runners Who Benefit From Medical Technology
Feb 18, 2011 Largest Study of Medtronic CoreValve® System Confirms Positive Clinical Outcomes
Jan 18, 2011 Medtronic Revises Design of CoreValve® U.S. Pivotal Trial
Jan 13, 2011 Medtronic Completes Acquisition of Ardian
Dec 21, 2010 Landmark Medtronic CoreValve® U.S. Clinical Trial Begins
Dec 21, 2010 Med-Tech Advance for 'Silent Killer': FDA Approves Medtronic Device to Fix Abdominal Aortic Aneurysms
Dec 9, 2010 Medtronic CoreValve® System Gains CE Mark for New Subclavian Approach to Transcatheter Aortic Valve Implantation
Nov 22, 2010 Medtronic Signs Agreement to Acquire Ardian
Nov 19, 2010 Medtronic Presents 30-Day Data On Valiant® Thoracic Stent Graft
Nov 19, 2010 Medtronic Presents One-Year Data On Endurant® Stent Graft
Nov 17, 2010 Medtronic Unveils EVARpro® Suite Of Services To Streamline Clinical Use Of Aortic Stent Grafts
Nov 1, 2010 Medtronic Receives FDA Approval of Talent Captivia® System for Endovascular Treatment of Thoracic Aortic Aneurysms
Oct 15, 2010 Medtronic Clinical Trial Receives FDA Approval to Evaluate New CoreValve® System for Aortic Valve Implantation
Sep 28, 2010 Medtronic Advances Research on Drug-Eluting Balloons for Coronary and Peripheral Artery Disease
Sep 22, 2010 Medtronic's Resolute Drug-Eluting Stent Shows Strong Performance In Second 'All Comers' Study
Sep 20, 2010 Medtronic Receives FDA Approval of Integrity® Coronary Stent
Sep 17, 2010 Medtronic Showcases Cardiovascular Devices at TCT 2010
Sep 10, 2010 Medtronic Releases 2010 Corporate Citizenship Report
Sep 7, 2010 Medtronic Gains CE Mark for Enhanced CoreValve® Delivery Catheter System with AccuTrak Stability Layer
Aug 30, 2010 Medtronic Launches Resolute Integrity Drug-Eluting Stent In Europe
Aug 8, 2010 Medtronic Opens Patient Care Centre in Beijing, China
Aug 6, 2010 Medtronic Completes Enrollment in Clinical Study of Complete SE® (Self-Expanding) Vascular Stent
Aug 5, 2010 First Patient Treated with Medtronic’s Valiant® Thoracic Stent Graft in Aortic Dissection Trial
May 26, 2010 Medtronic CoreValve® System Shows Long-Term Efficacy and Durability in Pivotal Trial
May 25, 2010 Multiple European Clinical Registries Show Important Benefits of Medtronic CoreValve® Transcatheter Aortic Valve System
May 25, 2010 Medtronic's Resolute® Drug-Eluting Stent Matches Market-Leading Rival in Large Head-To-Head Study
May 20, 2010 Cardiovascular Devices from Medtronic Featured Prominently at EuroPCR
May 19, 2010 First Patient Treated with Valiant® Thoracic Stent Graft in Medtronic ’s “RESCUE” Clinical Study
Apr 21, 2010 Medtronic Receives FDA Approval for New Indication for Complete® SE Vascular Stent
Mar 14, 2010 Medtronic's Endeavor Stent Continues to Demonstrate Compelling and Consistent Long-Term Clinical Results
Mar 12, 2010 Medtronic Starts International Study of CoreValve® Transcatheter Aortic Valve System
Jan 25, 2010 Medtronic to Acquire Invatec and Affiliated Companies
Jan 25, 2010 Medtronic Receives FDA Approval for First Replacement Heart Valve Implanted Without Surgery
Jan 21, 2010 Medtronic Pledges $1 Million to Haiti Earthquake Relief
Jan 15, 2010 Medtronic Pledges Over $250,000 to Haiti Earthquake Relief
Dec 8, 2009 Medtronic Hires Renowned Cardiologist as Vice President of Medical Affairs for Coronary and Peripheral Business
Dec 2, 2009 Medtronic Names Michael J. Coyle as Executive Vice President and Group President of Cardiology Businesses
Nov 25, 2009 Medtronic CEO William Hawkins to Speak at 21st Annual Piper Jaffray Healthcare Conference
Nov 24, 2009 Medtronic Second Quarter Revenue Increases 8% to $3.838 Billion; Raises EPS Guidance for Current Fiscal Year
Nov 19, 2009 Medtronic Chairman and CEO Bill Hawkins Comments on U.S. Senate's Revised Medical Device Industry Fee Proposal
Oct 13, 2009 Medtronic Starts Study of Interventional Erectile Dysfunction Therapy
Oct 5, 2009 2009 Medtronic Twin Cities Marathon “Global Heroes” Celebrate Accomplishment
Sep 21, 2009 Medtronic’s Resolute® Drug-Eluting Stent Maintains Strong, Sustained Efficacy and Safety in Long-Term Follow-Up
Sep 21, 2009 Endeavor® Stent Reduced Risk of Heart Attack/Cardiac Death by 48% at Three Years Compared to Taxus ® Stent in Large Study
Sep 18, 2009 Medtronic Expects New Data on Drug-Eluting Stents and Transcatheter Heart Valves to Feature at TCT 2009
Aug 25, 2009 Medtronic Reports First Quarter Revenue of $3.9 Billion
Aug 14, 2009 Medtronic to Announce Financial Results for Its First Fiscal Quarter
Aug 6, 2009 Medtronic Awarded $57 Million in Patent Dispute with AGA Medical Corporation
Jul 27, 2009 Medtronic and Abbott Laboratories Resolve Global Vascular Patent Disputes
Jun 15, 2009 Talent Stent Graft Shows Durable Performance in Patients with Abdominal Aortic Aneurysms
May 20, 2009 Medtronic’s CoreValve Shows Subclavian Access Success in Patients Contraindicated for Femoral Approach
May 19, 2009 Endeavor Drug-Eluting Stent Is First to Receive CE Mark for Treating Acute Coronary Syndrome
May 19, 2009 New Data From ENDEAVOR-II Challenges Conventional Wisdom on Drug-Eluting Stents
May 18, 2009 Medtronic to Participate in the Piper Jaffray Post-EuroPCR Summit
May 15, 2009 New Data on Endeavor Stent's Long-Term Safety and Efficacy to Be Featured at Interventional Cardiology Congress
May 14, 2009 Medtronic Completes Enrollment in International Post-Market Study of Resolute Drug-Eluting Stent
Apr 27, 2009 Medtronic Starts Enrollment in THRIVE, U.S. Post-Market Study of the Talent ™ Thoracic Stent Graft
Apr 3, 2009 Medtronic Launches Driver Sprint RX Coronary Stent System Worldwide

Source: Medtronic Inc.

Angioplasty.Org Home •  PatientCenter

this press release is posted as a reader service by Angioplasty.org,
an independent educational health site
which has received support from
Medtronic, Inc., Toshiba America Medical Systems, Volcano Corporation, Terumo Medical Corporation
Cardium Therapeutics, Inc. and Lenox Hill Heart and Vascular Institute of NY
All content, including text, photos and video
©Copyright Venture Digital LLC 1996-2012